The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...

Novo Nordisk said Monday that it had entered into a license agreement with a Chinese company developing a competitor to ...

GLP-1 weight loss drugs cost CT’s Medicaid program $85 million in FY 2024, 35% of annual Medicaid pharmaceutical budget ...

A Call for Scrutiny on Weight-Loss Medications** Concerns are mounting as one man's alarming experience with the weight-loss drug Ozempic brings to light the urgent need for scrutiny over the safety ...

Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult ...

Amy Schumer has revealed that she's back on a new weight loss drug after her "horrible experience" with Wegovy.

The latest microdosing trend isn’t shrooms or acid. It’s Ozempic.

Amy Schumer opened up about taking the weight loss drug Mounjaro after previously ‘horrible experience’ while on Wegovy.

LOS ANGELES, CALIFORNIA: Amy Schumer candidly opened up about her experience of taking weight loss medication in a recent video while also taking a subtle dig at Meghan Markle . The 43-year-old ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

Ozempic, a medication for type 2 diabetes and weight loss, mimics the action of GLP-1 to regulate blood sugar and appetite. Although Ozempic itself isn't found in food, high-fiber and probiotic ...